Table 1.

Patient characteristics

	N
Number of patients enrolled	73
With pharmacokinetic data	66
With pharmacokinetic data and genotype	47
Age (years)
Median	61
Range	29–80
Sex
Female	31
Male	42
Ethnicitya
Caucasian	54
Black	13
Asian	2
Hispanic	3
Otherb	1
Cancer diagnosis
Colorectal	25
Prostate	9
Mesothelioma	5
Other	34
Number of cycles/patient
Median	2
Range	1–13
Dosing schedule
Daily	41
Twice daily	32

^aSelf-reported ethnicity.

^b50% White Hispanic and 50% Native American.